Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD
5 Просмотры
administrator
07/30/23
Dr. Shaw describes the current data supporting the use of EGFR and ALK targeted therapies in treating molecularly genotyped patients with advanced NSCLC at the 2011 Chabner Colloquium.
Показать больше
Комментарии Facebook
Комментариев нет